Rosetta Genomics To Raise $6.0 Million In Concurrent Private Placement And Registered Direct Offerings
Rosetta Genomics, Ltd. (“Rosetta”) (NASDAQ: ROSG), a leading developer
and provider of microRNA-based molecular diagnostics, today announced it
has entered into definitive agreements with investors to purchase an...
Richard Heckmann is one of a growing number of investors who believe they've been cheated by a special class of Chinese company, one that gains access to U.S. capital markets via a reverse takeover, or RTO.